Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M303679200 on June 19, 2003

J. Biol. Chem., Vol. 278, Issue 36, 33912-33919, September 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/33912    most recent
M303679200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Argañaraz, E. R.
Right arrow Articles by Lama, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Argañaraz, E. R.
Right arrow Articles by Lama, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enhanced CD4 Down-modulation by Late Stage HIV-1 nef Alleles Is Associated with Increased Env Incorporation and Viral Replication*

Enrique R. Argañaraz {ddagger} §, Michael Schindler ¶, Frank Kirchhoff ¶, María J. Cortes {ddagger} and Juan Lama {ddagger} || **

From the {ddagger}Department of Medicine, School of Medicine and the ||Rebecca and John Moores Cancer Center, University of California, La Jolla, California 92093-0665 and the Department of Virology, University of Ulm, 89081 Ulm, Germany

Three viral proteins participate in the down-modulation of CD4 in human immunodeficiency virus type 1 (HIV-1)-infected cells. The underlying mechanisms have been extensively investigated. However, the physiological relevance of this phenomenon remains poorly understood. To address the role of CD4 down-modulation in HIV-1 pathogenesis in vivo, we have characterized the functional properties of nef alleles isolated from seven HIV-1-infected patients at either the stage of AIDS (late alleles) or during the asymptomatic phase of infection (early alleles). HIV-1 variants carrying these nef alleles showed striking differences in CD4 down-modulation, virus infectivity, and replication properties. Infection of T cells with late strains resulted in production of viral particles with enhanced infectivity, as compared with variants carrying early nef alleles. These differences in infectivity were observed only when viruses were produced in cells with high levels of the viral receptor, suggesting a functional link between CD4 levels and the ability of Nef to down-modulate CD4 and to enhance viral infectivity. Similarly, late nef alleles were substantially more active than early nef genes in stimulating HIV-1 replication in high CD4-positive cells, including primary lymphocytes, but not in cells expressing low levels of the CD4 receptor. Single-round assays showed that differences in infectivity between late and early strains are largely reduced when evaluated in target cells with high levels of CD4, suggesting that the inhibitory effect occurs at the entry step. Supporting this, enhanced CD4 down-modulation by late nef alleles was associated with higher levels of envelope incorporation into viral particles, a phenomenon that likely accounted for the augmented infectivity. Our data suggest a mechanistic link between the Nef-mediated CD4 down-modulation and the enhancement of replication in CD4-positive lymphocytes. As progression to disease occurs, HIV-1 Nef variants with enhanced ability to down-modulate CD4 are selected. These strains efficiently overcome the deleterious effects of CD4 and replicate more aggressively in CD4-positive primary lymphocytes. These results highlight the importance of the virus-induced CD4 down-modulation in HIV-1 pathogenesis.


Received for publication, April 9, 2003 , and in revised form, June 16, 2003.

* This work was supported by grants from the National Institutes of Health (NIH, Grant DA13866) and the Campbell Foundation (to J. L.), by NIH Grant 5P30AI36214-10 to the UCSD Center for AIDS Research, by a grant from the Conselho Nacional de Desemvolvimento Cientifico e Tecnologico (Brazil) (to E. R. A.), and by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Wilhem-Sander-Stiftung (to M. S. and F. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Current address: Departamento de Ciências Farmaceúticas, Faculdade de Ciências da Saúde, Universidade de Brasilia, Brasilia DF 70910-900, Brazil.

** To whom correspondence should be addressed: 9500 Gilman Dr., School of Medicine, Dept. Code 0665, University of California, La Jolla, CA 92093-0665. Tel.: 858-822-4211; Fax: 858-534-7743; E-mail: jlama{at}ucsd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
N. Laguette, C. Bregnard, J. Bouchet, A. Benmerah, S. Benichou, and S. Basmaciogullari
Nef-Induced CD4 Endocytosis in Human Immunodeficiency Virus Type 1 Host Cells: Role of p56lck Kinase
J. Virol., July 15, 2009; 83(14): 7117 - 7128.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Laguette, S. Benichou, and S. Basmaciogullari
Human Immunodeficiency Virus Type 1 Nef Incorporation into Virions Does Not Increase Infectivity
J. Virol., January 15, 2009; 83(2): 1093 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Priceputu, Z. Hanna, C. Hu, M.-C. Simard, P. Vincent, S. Wildum, M. Schindler, F. Kirchhoff, and P. Jolicoeur
Primary Human Immunodeficiency Virus Type 1 Nef Alleles Show Major Differences in Pathogenicity in Transgenic Mice
J. Virol., May 1, 2007; 81(9): 4677 - 4693.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Crotti, F. Neri, D. Corti, S. Ghezzi, S. Heltai, A. Baur, G. Poli, E. Santagostino, and E. Vicenzi
Nef Alleles from Human Immunodeficiency Virus Type 1-Infected Long-Term-Nonprogressor Hemophiliacs with or without Late Disease Progression Are Defective in Enhancing Virus Replication and CD4 Down-Regulation
J. Virol., November 1, 2006; 80(21): 10663 - 10674.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Munch, M. Schindler, S. Wildum, E. Rucker, N. Bailer, V. Knoop, F. J. Novembre, and F. Kirchhoff
Primary Sooty Mangabey Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 2 nef Alleles Modulate Cell Surface Expression of Various Human Receptors and Enhance Viral Infectivity and Replication
J. Virol., August 15, 2005; 79(16): 10547 - 10560.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Rucker, J.-C. Grivel, J. Munch, F. Kirchhoff, and L. Margolis
Vpr and Vpu Are Important for Efficient Human Immunodeficiency Virus Type 1 Replication and CD4+ T-Cell Depletion in Human Lymphoid Tissue Ex Vivo
J. Virol., November 15, 2004; 78(22): 12689 - 12693.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Rucker, J. Munch, S. Wildum, M. Brenner, J. Eisemann, L. Margolis, and F. Kirchhoff
A Naturally Occurring Variation in the Proline-Rich Region Does Not Attenuate Human Immunodeficiency Virus Type 1 Nef Function
J. Virol., September 15, 2004; 78(18): 10197 - 10201.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Kirchhoff, M. Schindler, N. Bailer, G. H. Renkema, K. Saksela, V. Knoop, M. C. Muller-Trutwin, M. L. Santiago, F. Bibollet-Ruche, M. T. Dittmar, et al.
Nef Proteins from Simian Immunodeficiency Virus-Infected Chimpanzees Interact with p21-Activated Kinase 2 and Modulate Cell Surface Expression of Various Human Receptors
J. Virol., July 1, 2004; 78(13): 6864 - 6874.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. A. Lundquist, J. Zhou, and C. Aiken
Nef Stimulates Human Immunodeficiency Virus Type 1 Replication in Primary T Cells by Enhancing Virion-Associated gp120 Levels: Coreceptor-Dependent Requirement for Nef in Viral Replication
J. Virol., June 15, 2004; 78(12): 6287 - 6296.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement